# Neuphoria Therapeutics Inc.: Form DEF 14A, filed Nov 12, 2024

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: DEF 14A
- Filed: 2024-11-12
- Accepted by EDGAR: Nov 12, 2024, 21:06 ET
- Period: 2024-12-11
- Accession: 0001213900-24-096782
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000121390024096782/ea0218389-def14a_bionomics.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000121390024096782/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000121390024096782/ea0218389-def14a_bionomics.htm

Filed Nov 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-096782. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.
